StreetAlpha.app
Home › Stocks › LFCR

Lifecore Biomedical, Inc. (LFCR)

Healthcare
$6.39
▲ +0.31%
LAST CLOSE · NOV 20

Lifecore Biomedical makes sterile injectable drugs and medical devices under contract for pharmaceutical and biotechnology companies. It last closed at $6.39 on Nov 20, up 0.31% on the day. The next earnings report for LFCR is expected around Mon, Mar 15, 2027. Over its last 8 reports the stock moved an average of 10.8% the session after earnings.

AI Auto Pilots
Is LFCR in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold LFCR.
Next report
Mar 15
Estimated date · Time not announced
Reported EPS
—
Not on file yet
Year ago EPS
—
Same quarter last year
Revenue
—
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
How LFCR moved after its last 8 reports
Average move the session after a report ±10.8%
Nov 4, 2026Time not announced+0.3%
Aug 5, 2026Time not announced+2.1%
May 6, 2026Time not announced−3.9%
Mar 16, 2026Time not announced−33.3%
Nov 6, 2025After the close+3.5%
Aug 7, 2025After the close−6.7%
Apr 3, 2025After the close−22.3%
Jan 2, 2025After the close+14.4%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on LFCRStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on LFCR
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on LFCR

Technical Analysis

LFCR · as of the Nov 20 close · updated each morning
Uptrend

The stock sits between its 20 and 50 day averages. It is 16% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 59). The nearest support is the Pivot at $6.38, and the nearest resistance the Pivot R1 at $6.40.

Short trendBullish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityLow, 1.0%/day
Key levels
$8.9852 week high+40.5%
$6.42Swing high (Nov 13)+0.5%
$6.4120 day average+0.3%
$6.40Pivot R1+0.2%
$6.39Last close
$6.38Pivot−0.2%
$6.38Pivot S1−0.2%
$6.36Swing low (Oct 21)−0.5%
$6.0150 day average−5.9%
$5.36200 day average−16.1%
$5.29100 day average−17.2%
$3.6252 week low−43.3%
Indicators
RSI (14)59.28Middle of its rangeNeutral
MACD0.08Below its signal lineBearish
Stochastic37.6Middle of its rangeNeutral
ADX (14)25.6Trending up
Williams %R-57.1Oversold below −80, overbought above −20Neutral
CCI (20)-71.3Oversold below −100, overbought above 100Neutral
Rate of change+0.5%Change over 10 sessionsBullish
ATR (14)$0.06Typical daily range, 1.0% of price
MA 10Above
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for LFCR

What happened before

See how LFCR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow LFCR usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How LFCR has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for LFCRHow many large options trades hit LFCR, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

LFCR Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●49 buying vs 43 selling
  • ●Held by funds +0.1 pts
  • ▲Funds holding +5
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding105100+5.0%
In funds' top 10440.0%
Held by funds67.1%67.0%+0.1 pts
New / increased16 / 3315 / 35−2.0%
Reduced / sold out32 / 1123 / 19+2.4%
Put/call ratio–0.00–
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See LFCR institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

LFCR Insider Trading

All filings →
Insider trading · 12 months
No open market trades in 12 months
Bought$00 buys · 0 insiders
Sold$00 sales · 0 insiders
DecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
May 28, 2025Aron R. English10% ownerSale1,386,060$6.58$9.1M
May 13, 202522NW Fund GP, LLC10% ownerSale12,334$7.00$86K
May 12, 202522NW Fund GP, LLC10% ownerSale51,496$7.03$362K
May 7, 202522NW GP, Inc.10% ownerSale41,091$7.05$290K
Jan 8, 2025Paul JosephsCEOBuy17,000$5.74$98K
Every insider buy and sale for LFCR over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See LFCR insider trades →

From SEC Form 4 filings by LFCR's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LFCR is in one of them and how their past LFCR trades turned out.

LFCR in the AI portfolios
Loading…

LFCR News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered LFCR in an article yet. Here's the latest on the wider market.

LFCR in the news

About Lifecore Biomedical

Lifecore Biomedical is a contract development and manufacturing organization based in Chaska, Minnesota. It develops and makes sterile injectable drugs and medical devices, filled into syringes, vials and cartridges. The company also produces hyaluronic acid, made by fermentation, in bulk form and for use in injectables used in eye and joint treatments. Its customers include pharmaceutical, biotechnology and device companies that rely on its aseptic filling and regulatory expertise.

Headquarters
Chaska, MN